跳至主要内容
临床试验/EUCTR2011-001310-34-AT
EUCTR2011-001310-34-AT进行中(未招募)不适用

Female Sexual Dysfunction in the Peri and Postmenopause: Effect of intranasal Oxytocin administration on sexual function and activity - OXY-COUP-PROT1.4

Med. Univ. Wien, Univ. Klinik für Innere Med. III0 个研究点目标入组 60 人开始时间: 2011年7月22日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Females with hypoactive sexual desire, arousal or orgasmic
  • disorders as assed by FSFI <27
  • Willingness to perfrom a pregnancy test every month for premenopausal women
  • Willingness to use contraception during the study period for premenopausal women
  • Ongoing sexual active relationship for at least 3 months
  • Female subjects must be older tha 40 years
  • Male subjects must be older than 18
  • Normal findings in the urogenital tract unless the investigator
  • considers an abnormality to be clinically irrelevant
  • Normal laboratory values unless the investigator considers an
  • abnormality to be clinically irrelevant
  • Normal findings in the medical history and physical
  • examination unless the investigator considers an abnormality
  • to be clinically irrelevant
  • Willingness to attempt sexual intercourse and/ or masturbation
  • at least two times per week
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • Abuse of alcoholic beverages or drugs, participation in a
  • clinical trial during 3 weeks preceding the study
  • Symptoms of a clinically relevant illness during 3 weeks
  • before the first study day
  • Presence of hepatic or renal dysfunction
  • Patients with known hypersensitivity to the study drug or any
  • ingredients
  • Blood or plasma donation during the previous 3 weeks
  • Any sexual pain conditions
  • Smoking > 10 cigarettes a day
  • BMI < 18 and > 35 kg/m2
  • Exclusion Criteria
  • For females
  • Lifelong, but not acquired, hypoactive sexual disorder
  • Chronic sinusitis or recurrent Ear-Nose-Throat infections
  • History or presence of cardiovascular disease and untreated
  • hypertension
  • Pelvic or genital diseases
  • Recurrent infections of the urogenital tract
  • Female genital prolapsed
  • History of hysterotomy
  • Presence of a major depression or any psychiatric disease
  • History of sexual abuse or primary sexual dysfunction
  • Exclusion Criteria
  • for males (n=5) with
  • erectile dysfunction
  • receiving a PDE 5
  • clinically significant renal insufficiency
  • clinically significant hepatobiliary disease
  • Hemoglobin A1c >13% at Visit 1.
  • chronic stable angina treated with long-acting nitrates, or
  • with chronic stable angina requiring short-acting nitrates in the last
  • 90 days, or with angina occurring during sexual intercourse in the
  • last 6 months.
  • unstable angina 6 months before Visit 1
  • history of myocardial infarction or coronary artery bypass graft
  • surgery within 90 days before Visit 1 or percutaneous coronary
  • intervention (for example, angioplasty or stent placement) within
  • 90 days before Visit 1.
  • supraventricular arrhythmia with an uncontrolled ventricular
  • response (mean heart rate >100 bpm) at rest, or have any history of
  • spontaneous or induced sustained ventricular tachycardia (heart
  • rate >100 bpm for !30 sec), or use an automatic internal
  • cardioverterdefibrillator.
  • history of sudden cardiac arrest.
  • evidence of congestive heart failure (NYHA Class 2 or
  • above) within 6 months before Visit 1.
  • new, significant cardiac conduction defect within 90 days before
  • systolic blood pressure >170 or <90 mm Hg or diastolic blood
  • pressure >100 or <50 mm Hg at screening (if stress is suspected,
  • 另有 10 项未显示

研究者

发起方
Med. Univ. Wien, Univ. Klinik für Innere Med. III

相似试验